SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Akorn Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Greg Butcher who wrote (54)11/5/1998 5:05:00 AM
From: vestor  Read Replies (2) of 101
 
I do not agree. Most institutions and mutal funds, unless small cap, will not touch a stock under $10. In theorythe monies received, if properly used to increase revenues thereby profits, could enhance prospects down the road. However in the short term, share holders and potential buyers take a dim view. They percieve dilution of earnings. Usually it is better accepted when the share price is over $20. and the last qtr. gave significant promise to future qtrs.... IMHO
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News